Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
UP FRONT MATTERSClinical Commentary
You have accessRestricted Access

Use of the ΔAG/ΔHCO3− Ratio in the Diagnosis of Mixed Acid-Base Disorders

Asghar Rastegar
JASN September 2007, 18 (9) 2429-2431; DOI: https://doi.org/10.1681/ASN.2006121408
Asghar Rastegar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

When a strong acid is added to plasma, one expects a quantitative relationship between excess anion gap (ΔAG) and bicarbonate deficit (ΔHCO3−) with the ΔAG/ΔHCO3− ratio close to unity. If true, then this ratio could be used to diagnose mixed acid-base disorders in patients with metabolic acidosis. Although the mean ratio in selected patients is close to unity, this ratio also has a wide range, making its use in individual patients problematic. The ratio should therefore be used cautiously in making a diagnosis of mixed acid-base disorders.

The anion gap (AG) is the difference between the concentration of selected positive and negative ions in the plasma. By convention, the AG is usually calculated as [Na − (Cl + HCO3−)], ignoring the concentration of potassium; in this commentary, HCO3− is also used synonymously for total CO2 (TCO2). Because the total concentration of anions and cations in plasma is equal, the AG reflects the difference between the concentration of unmeasured anions and cations.1 A normal AG primarily reflects the concentration of nonbicarbonate buffers including albumin, phosphate, sulfate, and organic acids. Albumin is the main component of the normal AG with each gram per deciliter contributing 2.5 mEq/L to the gap calculation.2 This contribution is pH dependent and increases with a rise in ambient pH. The elevated AG seen in metabolic alkalosis is due primarily to an increase in albumin concentration and a lesser extent to alkaline pH.3 The normal range for the AG varies from 3 to 11 to 8 to 16 mEq/L, depending on the instrument used to measure serum electrolytes, especially chloride.4 The range, however, is wide, regardless of the instrument used. To evaluate the AG in a patient, it is therefore important to know the normal range in your laboratory and compare the present AG with baseline AG, both corrected for albumin concentration and, if indicated, serum pH. Sometimes the baseline AG has to be estimated on the basis of the albumin concentration at the time of evaluation.

When a strong acid (HA) is added to the plasma, it dissociates to its base (A−) and H+ ion. Hydrogen is then neutralized by both bicarbonate and nonbicarbonate buffers present in extra- and intracellular compartments, resulting in a drop in serum bicarbonate (Figure 1). The accumulated A−, an unmeasured anion, then raises the AG. The resultant excess AG (ΔAG), therefore, serves as a footprint for the accumulation of a strong acid in plasma. ΔAG, of course, often contains more than a single anion. Gabow et al.,5 studying an unselected population with AG metabolic acidosis (AGMA), could not account for 23% (8.7 mEq/L) of the gap. Forni et al.,6 in a group of intensive care unit patients with lactic acidosis, diabetic ketoacidosis (DKA), and acidosis of unknown cause, noted the presence of significant amounts (3 to 5 mEq/L) of Kreb cycle intermediates, including citrate, isocitrate, α-ketoglutarate, and d-lactate. These metabolites accounted for some but not all of the unknown anions.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Factors affecting ΔAG/ΔHCO3− ratio. I, distribution space for A− and H+; II, metabolism of A−; III, renal handling of A− and H+; ECF, extracellular fluid; ICF, intracellular fluid.

Metabolic acidosis is due to either loss of bicarbonate or net addition of strong acid(s). In the former, no new anion is added and the AG does not change, resulting in hyperchloremic metabolic acidosis (HCMA). In this disorder, there is a lack of correlation between the ΔAG and ΔHCO3−, with the ratio of ΔAG/ΔHCO3− falling below unity (1.0) and sometimes approaching zero. When a strong acid (HA) is added to plasma either as a result of a decrease in excretion, such as in renal failure, or as a result of addition, such as in DKA or in methanol poisoning, AGMA develops. In this disorder, one expects a direct quantitative relationship between ΔAG and ΔHCO3− with a ratio close to unity. If true, then a mixed disturbance is suspected when the ratio deviates from unity. If the ratio is significantly lower than 1, then an underlying HCMA or respiratory alkalosis can be inferred; if greater than 1, then an underlying metabolic alkalosis or respiratory acidosis may be present. One could also calculate the so-called ΔΔ—the difference between ΔAG and ΔHCO3−. In pure AGMA, the ΔΔ would be zero. If the ΔAG is greater than the ΔHCO3−, then the ΔΔ would be positive. This is plausible only if the initial bicarbonate is higher than normal, reflecting the presence of a hidden metabolic alkalosis or respiratory acidosis. If the ΔΔ is a negative number because the ΔAG is less than the ΔHCO3−, then the initial bicarbonate must be lower than normal, reflecting the presence of a HCMA or respiratory alkalosis. Use of either the ΔAG/ΔHCO3− ratio or the ΔΔ also requires that A− and H+ have a similar distribution space and renal and nonrenal clearance and that the overall contribution of albumin and other nonbicarbonate buffers to the AG remain stable (Figure 1). However, as summarized in Figure 1, the ratio or ΔΔ would change if these conditions were not met.

The utility of the ΔAG/ΔHCO3− ratio is best studied in DKA, in which production of ketoacids is associated with an acute drop in serum bicarbonate and a rise in AG. Patients with DKA often present with vomiting, volume depletion, and/or infection, conditions that could affect acid-base status. Adrogué et al.7 recently summarized seven studies in patients with DKA and noted that the mean rise in AG was similar to the mean decrease in bicarbonate, resulting in a ΔAG/ΔHCO3− ratio close to 1.0. In the largest study involving 242 patients, although the mean ΔAG/ΔHCO3− ratio was close to unity, there was no relationship between ΔAG and ΔHCO3−, and the ratio varied from 0 to 2.8 Similar variations in this ratio have been noted in patients with ESRD.9 In a carefully done study of 100 admissions for DKA, Paulson,10 after a careful review of clinical data, selected 20 admissions with simple metabolic acidosis. Slope of regression lines between ΔAG to ΔHCO3− in this group and 43 normal control subjects was close to unity but with a wide 95% confidence interval of ±8 mEq/L. Given this wide interval, two conclusions can be drawn: (1) The AG in itself is often a poor predictor of severity of metabolic acidosis, and (2) the ΔAG/ΔHCO3− ratio should be used cautiously in diagnosing a mixed acid-base disturbances.

When this ratio was further evaluated in light of volume status (blood urea nitrogen [BUN] used as a surrogate for volume status), there was a direct relationship between BUN and this ratio as well as among BUN, serum albumin, and the AG.8,10 This relationship is primarily due to the effect of volume status on renal clearance of keto-anions. Lower renal clearance of keto-anion in hypovolemia also explains two other observations: (1) That volume expansion is associated with the development of HCMA,8,11 and (2) that patients with higher ΔAG/ΔHCO3− ratios on admission have a more rapid rise in bicarbonate generated by metabolism of keto-anions.8 In summary, the expected stoichiometric relationship seems true only of the mean data, with a wide range for individual patients. In addition, volume depletion, by changing the renal excretion of keto-anions, has a major impact on this ratio.

Given this complex relationship, how should the ΔAG/ΔHCO3− ratio be used to diagnose mixed disturbance? Some authors, using the data from Adrogué et al.,12 suggested that mixed disturbances should be considered if the ratio is <0.8 or >1.2. Paulson, applying this rule to a group of normal control subjects and patients with simple metabolic acidosis, noted that the formula erroneously categorized 56% of this group as mixed disturbances. Use of the 95% confidence interval of ±8 mEq/L increased the specificity to 97% but with a poor sensitivity of only 27%.13 In addition, one should be cautious in applying these rules developed in DKA to patients with other types of metabolic acidosis. Oh et al.11 found a mean ratio close to unity in a group of patients with DKA but as high as 1.6 in patients with phenformin-induced lactic acidosis. This is probably due to the lower renal clearance of lactate compared with keto-anions. It is interesting that in exercise-induced lactic acidosis, the ratio remains close to unity up to a serum lactate of 15 mEq/L but increases significantly as the lactate level rises further and serum pH drops below 7.15.14 This finding may be due to better buffering at lower pH by nonbicarbonate buffers, including hemoglobin. The difference between DKA and lactic acidosis, however, is multifactorial and reflects the differences in distribution space, renal clearance, duration, and severity of acidosis as well as volume status.

Given the complexity in the relationship between ΔAG and ΔHCO3−, how, then, should clinicians use this ratio? I think we should abandon diagnosing mixed disturbance solely on the basis of the use of ΔAG/ΔHCO3− ratio of <0.8 or >1.2. Although the confidence interval derived by Paulson provides greater specificity, it has poor sensitivity and should therefore be used cautiously.15 To diagnose a mixed acid-base disorder, we therefore need to use all available data and not depend on a single formula. I therefore suggest the following:

  1. Know the normal AG range for your laboratory.

  2. Correct the AG for serum albumin concentration, and always use corrected AG.

  3. Compare the AG with the baseline AG in your patient rather than with a normal range.

  4. Use all clinical information, including historical and laboratory data, in making a diagnosis of mixed acid-base disturbance.

  5. Follow patients with a complex presentation carefully because the diagnosis of a hidden disorder(s) may become apparent by evaluating response to therapy.

  6. Use theΔAG/ΔHCO3− ratio orΔΔ as one piece of evidence among many in making your final diagnosis. Be aware of its limitations as discussed here.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • © 2007 American Society of Nephrology

References

  1. ↵
    Emmett M, Narins R: Clinical use of the anion gap. Medicine (Baltimore) 56 : 38 –54, 1977
    OpenUrlPubMed
  2. ↵
    Figge J, Jabor A, Kazda A, Fencl V: Anion gap and hypoalbuminemia. Crit Care Med 26 : 1807 –1810, 1998
    OpenUrlCrossRefPubMed
  3. ↵
    Adrogue HJ, Brensilver J, Madias NE: Changes in the plasma anion gap during chronic metabolic acid-base disturbances. Am J Physiol 4 : F291 –F291, 1978
    OpenUrl
  4. ↵
    Lolekha PH, Vanavanan S, Teerakarnjana N, Chaichanajarenkukl U: Reference ranges of electrolytes and anion gap on the Beckman, E4A, Beckman Synchron CX5, Nova CRT, and Nova Stat Profile Ultra. Clin Chim Acta 307 : 87 –93, 2001
    OpenUrlCrossRefPubMed
  5. ↵
    Gabow PA, Kaehny WD, Fennessey PV, Goodman SL, Gross PA, Schrier RW: Diagnostic importance of an increased anion gap. N Engl J Med 303 : 854 –858, 1980
    OpenUrlCrossRefPubMed
  6. ↵
    Forni LG, McKinnon,W, Lord GA, Treacher DF, Peron JM, Hilton PJ: Circulating anion usually associated with the Kreb cycle in pa-tients with metabolic acidosis. Crit Care 9 : R591 –R595, 2005
    OpenUrlCrossRefPubMed
  7. ↵
    Adrogue HJ, Madias NE: Diabetic and other forms of ketoacidosis. In: Acid-Base Disorders and Their Treatment, edited by Gennari FJ, Adrouge HJ, Galla JH, Madias NE, London, Taylor & Francis, 2005 , pp 313 –351
  8. ↵
    Adrogué HJ, Wilson H, Boyd AE, Suki WN, Eknoyan G: Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 307 : 1603 –1610, 1982
    OpenUrlCrossRefPubMed
  9. ↵
    Wallia R, Greenberg A, Piraino B, Mitro R, Puschett JB: Serum electrolyte pattern in end-stage renal disease. Am J Kidney Dis 8 : 98 –104, 1986
    OpenUrlPubMed
  10. ↵
    Paulson WD: Anion gap-bicarbonate relation in diabetic ketoacidosis. Am J Med 81 : 995 –1000, 1986
    OpenUrlCrossRefPubMed
  11. ↵
    Oh MS, Carroll HJ, Goldstein DA, Fein IA: Hyperchloremic acidosis during the recovery phase of diabetic keto acidosis. Ann Intern Med 89 : 925 –927, 1978
    OpenUrlCrossRefPubMed
  12. ↵
    Elisaf M, Tsatsoulis AA, Katopodis KP, Siamopolous KC: Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. Diabetes Res Clin Pract 34 : 23 –27, 1966
    OpenUrlCrossRef
  13. ↵
    Paulson WD, Gadallah MF: Diagnosis of mixed acid-base disorders in diabetic ketoacidosis. Am J Med Sci 306 : 295 –300, 1993
    OpenUrlPubMed
  14. ↵
    Osnes JB, Hermansen L: Acid-base balance after maximal exercise of short duration. J Appl Physiol 32 : 59 –62, 1972
    OpenUrlPubMed
  15. ↵
    DiNubile MJ: The increment in the anion gap; overextension of a concept? Lancet 2 : 951 –953, 1988
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 18 (9)
Journal of the American Society of Nephrology
Vol. 18, Issue 9
September 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Use of the ΔAG/ΔHCO3− Ratio in the Diagnosis of Mixed Acid-Base Disorders
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of the ΔAG/ΔHCO3− Ratio in the Diagnosis of Mixed Acid-Base Disorders
Asghar Rastegar
JASN Sep 2007, 18 (9) 2429-2431; DOI: 10.1681/ASN.2006121408

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Use of the ΔAG/ΔHCO3− Ratio in the Diagnosis of Mixed Acid-Base Disorders
Asghar Rastegar
JASN Sep 2007, 18 (9) 2429-2431; DOI: 10.1681/ASN.2006121408
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Disclosures
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

UP FRONT MATTERS

  • COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation
  • The Aftermath of AKI: Recurrent AKI, Acute Kidney Disease, and CKD Progression
  • Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
Show more UP FRONT MATTERS

Clinical Commentary

  • Trends in Discharge Claims for Acute Myocardial Infarction among Patients on Dialysis
  • Reassessing Medical Risk in Living Kidney Donors
  • Commentary on the 2014 BP Guidelines from the Panel Appointed to the Eighth Joint National Committee (JNC 8)
Show more Clinical Commentary

Cited By...

  • Pyroglutamic acidosis in association with therapeutic paracetamol use
  • A clinical approach to paediatric acid-base disorders
  • Analysis of Acid-Base Disorders in Patients With Chronic Respiratory Failure
  • Clinical Utility of Stewart's Method in Diagnosis and Management of Acid-Base Disorders
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire